Dual-Mechanism Investigational Agent Acts on Diabetes and Metabolic Complications

Kenneth J Bender, PharmD, MA An investigational agent with dual mechanisms of action demonstrated benefit on markers of both diabetes and non-alcoholic steatohepatitis (NASH), in studies presented at the American Diabetes Association (ADA) Scientific Sessions meeting in San Francisco, CA June 7-11.
Source: ConsultantLive - Category: Internal Medicine Tags: Diabetes Type 2 Source Type: news